• 11
  • 4
  • Favorite

Will Regeneron's COVID Cocktail Win Be Short-Lived?

Motley Fool2021-04-21

Regeneron Pharmaceuticals (NASDAQ:REGN) recently racked up a couple of additional successes with late-stage studies of its COVID-19 antibody cocktail REGEN-COV. In this Motley Fool Live video recorded...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment4

  • Bencessco
    ·2021-04-21
    ... 
    Reply
    Report
  • pjetan
    ·2021-04-21
    Interesting
    Reply
    Report
  • LoBangKing
    ·2021-04-21
    No idea
    Reply
    Report
  • Loqir
    ·2021-04-21
    It depends 
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial